Created in 2008, Newpharma is the leading Belgian online pharmacy and among the largest in Europe with more than 1 million patients. From its website www.newpharma.be, it offers delivery to 12 countries from Liège. The company has four other local websites for France, the Netherlands, Germany and Austria. With more than 30,000 products and 750 brands, Newpharma stands out due to an optimal specific logistics approach and the capacity to deliver the majority of orders placed before noon within 24 hours. In 2017, Newpharma achieved a turnover of 63 million euros, with 110 employees.
A reward for a young company with strong growth potential
Since 2013, young companies from Brussels and Wallonia with high potential and showing strong development, have been able to compete for the title of ‘Scale-up de l’Année’, which was still called ‘L’Entreprise Prometteuse de l’Année’ last year. This year’s nominees were: Aproplan, Qover, Newpharma and Skylane Optics. Newpharma was chosen by the jury to succeed the 2017 winner, Trasis.
“Starting from scratch, Newpharma has managed to create a disruptive e-commerce model in a highly traditional market. In just a few years, the company has established its reputation and generated a very significant number of jobs. It is now focussing on conquering the international market, based on a well-oiled, highly organized logistics system. Its highly dedicated management has demonstrated the energy and abilities required to make it ‘L’Entreprise de l’Année®’one day”, commented the president of the jury, Baron Pierre Rion.
“Since the start of this competition in 2013, we have wanted to support and encourage young companies with great growth potential in Brussels and Wallonia. Newpharma fits this image perfectly. The company has already achieved some excellent performances and is ideally placed to continue its expansion and become ‘L’Entreprise de l’Année®’ someday. The company is a worthy successor to Trasis, last year’s winner”, said Carl Laschet, Associate Partner at EY.